1. Home
  2. WETH vs GDTC Comparison

WETH vs GDTC Comparison

Compare WETH & GDTC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

WETH

Wetouch Technology Inc.

HOLD

Current Price

$1.77

Market Cap

16.6M

Sector

N/A

ML Signal

HOLD

Logo CytoMed Therapeutics Limited

GDTC

CytoMed Therapeutics Limited

HOLD

Current Price

$0.92

Market Cap

15.5M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
WETH
GDTC
Founded
1992
2018
Country
China
Singapore
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
16.6M
15.5M
IPO Year
N/A
2023

Fundamental Metrics

Financial Performance
Metric
WETH
GDTC
Price
$1.77
$0.92
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
44.4K
1.7M
Earning Date
11-12-2025
04-24-2026
Dividend Yield
N/A
N/A
EPS Growth
81.55
N/A
EPS
0.62
N/A
Revenue
$43,519,385.00
$573,193.00
Revenue This Year
N/A
$5.37
Revenue Next Year
N/A
N/A
P/E Ratio
$2.74
N/A
Revenue Growth
6.08
63.03
52 Week Low
$0.76
$0.73
52 Week High
$3.68
$3.68

Technical Indicators

Market Signals
Indicator
WETH
GDTC
Relative Strength Index (RSI) 52.39 43.45
Support Level $1.44 $0.87
Resistance Level $1.79 $1.12
Average True Range (ATR) 0.14 0.12
MACD 0.01 0.03
Stochastic Oscillator 62.92 48.26

Price Performance

Historical Comparison
WETH
GDTC

About WETH Wetouch Technology Inc.

Wetouch Technology Inc is a touch panel supplier focused on R&D, production, and sales of touch screen products. It offers touchscreens for a variety of applications, including GPS/car entertainment panels for the automotive industry, industrial human-machine interface, financial and banking terminals, point of sale, lottery and gaming machines, smart home, robots, and charging stations. The company sells touchscreen products both domestically in China and internationally. The company generates the majority of its revenue from the PRC, followed by the Republic of China and Korea.

About GDTC CytoMed Therapeutics Limited

CytoMed Therapeutics Ltd is a pre-clinical biopharmaceutical company focused on harnessing its proprietary technologies to create novel cell-based immunotherapies for the treatment of human cancers. The company's segment include: the business of innate immune cell-based immunotherapy, pluripotent stem cell-based therapy and undertaking the research and development of immune cell and stem cell-based therapy; and the business of processing and banking of cells including cord blood stem cells, research and development on cord blood derived cell-based therapy. Geographically, the company operates in Singapore and Malaysia which is the majority revenue generator.

Share on Social Networks: